The GLP-1 type drugs, developed for the management of Type 2 diabetes, are creating excitement about their use for disorders resistant to treatment or for which limited treatments are available, such as addiction and infertility
Serious but Rare Side Effects Although less common, some serious side effects can occur: Pancreatitis: Inflammation of the pancreas is a rare but serious risk
With commercial insurance and a prior auth, the medication copay is usually about $25/mo
In a 4-year CV outcomes trial (Trial 7), cholelithiasis was reported in 1.1% of patients treated with RYBELSUS 14 mg and in 0.9% of placebo-treated patients
A recent study entitled Elevation of glutathione as a therapeutic strategy in Alzheimers disease concludes: Increasing glutathione remains a promising therapeutic strategy to slow or prevent MCI and Alzheimers disease. Considering that glutathione levels continue to decline as we age, and that both AD and MCI increase with age, supplementation with effective glutathione can play an important role in prevention, or slowing the progression of this disease